{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:31:37Z","timestamp":1746851497817,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12328-024-02050-6","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T03:01:58Z","timestamp":1730343718000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The first case of primary malignant melanoma of the esophagus to achieve pathologic complete response after preoperative ipilimumab\u2009+\u2009nivolumab followed by resection"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1277-1186","authenticated-orcid":false,"given":"Ryo","family":"Shibayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentoku","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Shimoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Ohkura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusuke","family":"Haruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harushi","family":"Udagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Takazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"key":"2050_CR1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0003-4975(10)61963-7","volume":"39","author":"G Chalkiadakis","year":"1985","unstructured":"Chalkiadakis G, Wihlm JM, Morand G. Primary malignant melanoma of the esophagus. Ann Thorac Surg. 1985;39:472\u20135.","journal-title":"Ann Thorac Surg"},{"key":"2050_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/CMR.0b013e3281c4a079","volume":"17","author":"B Li","year":"2007","unstructured":"Li B, Lei W, Shao K, et al. Characteristics and prognosis of primary malignant melanoma of the esophagus. Melanoma Res. 2007;17:239\u201342.","journal-title":"Melanoma Res"},{"key":"2050_CR3","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.3390\/cancers14153725","volume":"14","author":"G Cazzato","year":"2022","unstructured":"Cazzato G, Cascardi E, Colagrande A, et al. The thousand faces of malignant melanoma: a systematic review of the primary malignant melanoma of the esophagus. Cancers (Basel). 2022;14:3725.","journal-title":"Cancers (Basel)"},{"key":"2050_CR4","doi-asserted-by":"publisher","first-page":"100811","DOI":"10.1016\/j.neo.2022.100811","volume":"30","author":"J Li","year":"2022","unstructured":"Li J, Guan W, Ren W, et al. Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus. Neoplasia. 2022;30:100811.","journal-title":"Neoplasia"},{"key":"2050_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/jso.24905","volume":"117","author":"H Sun","year":"2018","unstructured":"Sun H, Gong L, Zhao G, et al. Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus. J Surg Oncol. 2018;117:588\u201396.","journal-title":"J Surg Oncol"},{"key":"2050_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00535-011-0490-y","volume":"47","author":"Y Iwanuma","year":"2012","unstructured":"Iwanuma Y, Tomita N, Amano T, et al. Current status of primary malignant melanoma of the esophagus: clinical features, pathology, management and prognosis. J Gastroenterol. 2012;47:21\u20138.","journal-title":"J Gastroenterol"},{"key":"2050_CR7","first-page":"1475","volume":"84","author":"S Sabanathan","year":"1989","unstructured":"Sabanathan S, Eng J, Pradhan GN. Primary malignant melanoma of the esophagus. Am J Gastroenterol. 1989;84:1475\u201381.","journal-title":"Am J Gastroenterol"},{"key":"2050_CR8","first-page":"1872","volume":"18","author":"T Hashimoto","year":"2019","unstructured":"Hashimoto T, Makino T, Yamasaki M, et al. Clinicopathological characteristics and survival of primary malignant melanoma of the esophagus. Oncol Lett. 2019;18:1872\u201380.","journal-title":"Oncol Lett"},{"key":"2050_CR9","doi-asserted-by":"publisher","first-page":"23804","DOI":"10.1038\/srep23804","volume":"6","author":"S Gao","year":"2016","unstructured":"Gao S, Li J, Feng X, et al. Characteristics and surgical outcomes for primary malignant melanoma of the esophagus. Sci Rep. 2016;6:23804.","journal-title":"Sci Rep"},{"key":"2050_CR10","first-page":"30571","volume":"S0022\u20135223","author":"L Dai","year":"2020","unstructured":"Dai L, Wang ZM, Xue ZQ, et al. Results of surgical treatment for primary malignant melanoma of the esophagus: a multicenter retrospective study. J Thorac Cardiovasc Surg. 2020;S0022\u20135223:30571\u20137.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2050_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10388-015-0484-6","volume":"12","author":"H Makuuchi","year":"2015","unstructured":"Makuuchi H, Takubo K, Yanagisawa A, et al. Esophageal malignant melanoma: analysis of 134 cases collected by the Japan Esophageal Society. Esophagus. 2015;12:158\u201369.","journal-title":"Esophagus"},{"key":"2050_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12893-017-0326-7","volume":"17","author":"S Kuwabara","year":"2017","unstructured":"Kuwabara S, Ebihara Y, Nakanishi Y, et al. Primary malignant melanoma of the esophagus treated with subtotal esophagectomy: a case report. BMC Surg. 2017;17:122.","journal-title":"BMC Surg"},{"key":"2050_CR13","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","volume":"377","author":"J Wolchok","year":"2017","unstructured":"Wolchok J, Chiarion-Sileni V, Gonzalez R, et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2017;377:1345\u201356.","journal-title":"N Engl J Med"},{"key":"2050_CR14","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/S1470-2045(18)30700-9","volume":"19","author":"FS Hodi","year":"2018","unstructured":"Hodi FS, Chiarion-Sileni V, Gonzalez R, et al. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial. Lancet Oncol. 2018;19:1480\u201392.","journal-title":"Lancet Oncol"},{"key":"2050_CR15","first-page":"528","volume":"8","author":"K Sasaki","year":"2018","unstructured":"Sasaki K, Uchikado Y, Omoto I, et al. Multidisciplinary therapy for metastatic primary malignant melanoma of the esophagus: a case repor. Mol Clin Oncol. 2018;8:528\u201332.","journal-title":"Mol Clin Oncol"},{"key":"2050_CR16","doi-asserted-by":"publisher","first-page":"e4283","DOI":"10.1097\/MD.0000000000004283","volume":"95","author":"K Inadomi","year":"2016","unstructured":"Inadomi K, Kumagai H, Arita S, et al. Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: a case report. Medicine (Baltimore). 2016;95:e4283.","journal-title":"Medicine (Baltimore)"},{"key":"2050_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijscr.2020.09.034","volume":"75","author":"F Endo","year":"2020","unstructured":"Endo F, Akiyama Y, Onishi M, et al. Primary esophageal malignant melanoma successfully treated with retroperitoneal recurrence after esophagectomy: a case report. Int J Surg Case Rep. 2020;75:152\u20136.","journal-title":"Int J Surg Case Rep"},{"key":"2050_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/1346-8138.16669","volume":"50","author":"A Takahashi","year":"2023","unstructured":"Takahashi A, Namikawa K, Ogata D, et al. Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma. J Dermatol. 2023;50:525\u201335.","journal-title":"J Dermatol"},{"key":"2050_CR19","doi-asserted-by":"crossref","unstructured":"Watson AS, Goutam S, Stukalin I et al. Association of immune-related adverse events, hospitalization, and therapy resumption with survival among patients with metastatic melanoma receiving single-agent or combination immunotherapy. JAMA Netw Open. 2022;1;5(12).","DOI":"10.1001\/jamanetworkopen.2022.45596"},{"key":"2050_CR20","first-page":"77","volume":"122","author":"N Attlassy","year":"2023","unstructured":"Attlassy N, Agbeh A, Patnaik R, et al. Primary malignant melanoma of the gastroesophageal junction treated with immunotherapy: a case report. WMJ. 2023;122:77\u201380.","journal-title":"WMJ"},{"key":"2050_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s13691-022-00582-7","volume":"12","author":"S Nambara","year":"2022","unstructured":"Nambara S, Sakaguchi Y, Tsuda Y, et al. Primary esophageal malignant melanoma without recurrence after surgery and adjuvant therapy with nivolumab. Int Cancer Conf J. 2022;12:100\u20133.","journal-title":"Int Cancer Conf J"},{"key":"2050_CR22","first-page":"65","volume":"50","author":"K Ho","year":"2023","unstructured":"Ho K, Hirata Y, Egawa T. A case of thoracoscopic subtotal esophagectomy for malignant esophageal melanoma. Gan To Kagaku Ryoho. 2023;50:65\u20138.","journal-title":"Gan To Kagaku Ryoho"},{"key":"2050_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s40792-022-01561-z","volume":"8","author":"K Hanada","year":"2022","unstructured":"Hanada K, Tsunoda S, Nomura M, et al. A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus. Surg Case Rep. 2022;8:206.","journal-title":"Surg Case Rep"},{"key":"2050_CR24","first-page":"1160","volume":"49","author":"Y Minagawa","year":"2022","unstructured":"Minagawa Y, Tanaka Y, Funatsuya T, et al. Successful postoperative recurrence treatment of malignant melanoma of the esophagus by anti-PD-1 and anti-CTLA-4 combined therapy\u2014a case report. Gan To Kagaku Ryoho. 2022;49:1160\u20132.","journal-title":"Gan To Kagaku Ryoho"},{"key":"2050_CR25","first-page":"e23250","volume":"14","author":"S Kashfi","year":"2022","unstructured":"Kashfi S, Marneni N, Sharma S, et al. Primary malignant melanoma of the esophagus in a 76-year-old female. Cureus. 2022;14:e23250.","journal-title":"Cureus"},{"key":"2050_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s13691-021-00515-w","volume":"11","author":"S Furune","year":"2021","unstructured":"Furune S, Kondo C, Takano Y, et al. Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment. Int Cancer Conf J. 2021;11:46\u20138.","journal-title":"Int Cancer Conf J"},{"key":"2050_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s40792-021-01336-y","volume":"7","author":"T Yamaguchi","year":"2021","unstructured":"Yamaguchi T, Fushida S, Kinoshita J, et al. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration. Surg Case Rep. 2021;7:253.","journal-title":"Surg Case Rep"},{"key":"2050_CR28","first-page":"10","volume":"13","author":"R Tsukamoto","year":"2021","unstructured":"Tsukamoto R, Ihara H, Takase M, et al. Immunotherapy against esophageal primary amelanotic malignant melanoma relapse. J Surg Case Rep. 2021;13:10.","journal-title":"J Surg Case Rep"},{"key":"2050_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13256-021-02928-w","volume":"15","author":"T Okamoto","year":"2021","unstructured":"Okamoto T, Nakano E, Yamauchi T. Complete remission in metastatic primary malignant melanoma of the esophagus with nivolumab: a case report. J Med Case Rep. 2021;15:345.","journal-title":"J Med Case Rep"},{"key":"2050_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13256-021-02821-6","volume":"15","author":"S Ito","year":"2021","unstructured":"Ito S, Tachimori Y, Terado Y, et al. Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report. J Med Case Rep. 2021;15:237.","journal-title":"J Med Case Rep"},{"key":"2050_CR31","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/1759-7714.13034","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Kong Y, Chi Z, et al. Primary malignant melanoma of the esophagus: a retrospective analysis of clinical features, management, and survival of 76 patients. Thorac Cancer. 2019;10:950\u20136.","journal-title":"Thorac Cancer"},{"key":"2050_CR32","first-page":"1251","volume":"47","author":"Y Matsumoto","year":"2020","unstructured":"Matsumoto Y, Hirasawa S, Natsume T, et al. A case of primary amelanotic malignant melanoma of the esophagus, wherein pseudoprogression was suspected during immune checkpoint inhibitor treatment. Gan To Kagaku Ryoho. 2020;47:1251\u20133.","journal-title":"Gan To Kagaku Ryoho"},{"key":"2050_CR33","first-page":"2012","volume":"46","author":"D Yamai","year":"2019","unstructured":"Yamai D, Ichikawa H, Kano Y, et al. A case of esophageal primary malignant melanoma that developed during the follow-up of esophageal melanocytosis. Gan To Kagaku Ryoho. 2019;46:2012\u20134.","journal-title":"Gan To Kagaku Ryoho"},{"key":"2050_CR34","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2217\/imt-2018-0011","volume":"10","author":"P Rochefort","year":"2018","unstructured":"Rochefort P, Roussel J, de la Fouchardi\u00e8re A, et al. Primary malignant melanoma of the esophagus, treated with immunotherapy: a case report. Immunotherapy. 2018;10:831\u20135.","journal-title":"Immunotherapy"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-024-02050-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:16:55Z","timestamp":1738329415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-024-02050-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2050"],"URL":"https:\/\/doi.org\/10.1007\/s12328-024-02050-6","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2024,10,31]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}